Epitopea strengthens top teams in fresh growth push
Epitopea, a transatlantic cancer immunotherapeutics company, has formed a dedicated clinical team and expanded its research team. The developments represent a significant milestone in the company’s ongoing progress in advancing its RNA-based immunotherapies, known as CryptiVaxTM, into clinical trials.